1. The Brain Symptom and Impact Questionnaire in brain metastases patients: a prospective long-term follow-up study
- Author
-
David Cella, Hany Soliman, Cyril Danjoux, Breanne Lechner, Rachel McDonald, Leigha Rowbottom, Edward Chow, Saurabh Ray, Arjun Sahgal, May Tsao, Liying Zhang, and Natalie Pulenzas
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Long term follow up ,Severity of Illness Index ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Surveys and Questionnaires ,Severity of illness ,medicine ,Humans ,Longitudinal Studies ,Prospective Studies ,Karnofsky Performance Status ,Neoplasm Metastasis ,Young adult ,Prospective cohort study ,Psychiatry ,Aged ,Ganglioglioma ,Aged, 80 and over ,Brain Neoplasms ,business.industry ,Brain ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,030220 oncology & carcinogenesis ,Quality of Life ,Physical therapy ,Female ,business ,030217 neurology & neurosurgery ,Research Article - Abstract
Aims: To assess the ability of the Brain Metastases Symptom and Impact Questionnaire (BASIQ) in evaluating symptoms and impact on daily life. Patients & methods: Patients with brain metastases completed BASIQ, Functional Assessment of Cancer Therapy-General, FACT-Brain at baseline and at 1, 2 and 3 months follow-ups. Results: Thirty-six patients completed all follow-ups. BASIQ correlated well (r ≥ 0.40) with FACT subscales, except for social/family and emotional wellbeing. Linear regression analysis found no significant changes in quality of life (QOL) over time in both the BASIQ and FACT scales. Therefore, the two questionnaires coincide as both detected nonchanges. Conclusion: The ability of the BASIQ in evaluating symptoms and impact on over longer assessment periods was supported by the FACT questionnaires.
- Published
- 2016